Induced sputum, exhaled NO, and breath condensate in occupational medicine

Journal of Occupational and Environmental Medicine

Volumn 54, Issue 8, 2012, Pages 922-927

  Chérot Kornobis, Nathalie ^a,b,c   Hulo, Sebastien ^a,b,c   De Broucker, Virginie ^a,b,c   Hassoun, Sidi ^a,b,c   Lepage, Nadège ^a,b,c   Edmé, Jean Louis ^a,b,c   Sobaszek, Annie ^a,b,c  

^a UNIV LILLE   (France)

^b UFR3S Pharmacie   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; BIOLOGICAL MARKER; HEAVY METAL; HYDROGEN PEROXIDE; MALONALDEHYDE; NITRIC OXIDE; NITROGEN OXIDE;

ARTICLE; ASBESTOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; EXHALATION; HUMAN; INFLAMMATION; LUNG CANCER; LUNG FIBROSIS; MASS SPECTROMETRY; OCCUPATIONAL ASTHMA; OCCUPATIONAL HEALTH; OXIDATIVE STRESS; SENSITIZATION; SPUTUM;

BIOLOGICAL MARKERS; BREATH TESTS; CYTOKINES; HUMANS; HYDROGEN PEROXIDE; ISOPROSTANES; LUNG DISEASES; MALONDIALDEHYDE; METALS, HEAVY; NITRIC OXIDE; OCCUPATIONAL HEALTH SERVICES; OXIDATIVE STRESS; SPUTUM;

EID: 84865445548     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31825a34b3     Document Type: Article

References (95)

1. Cherot-Kornobis N, Edme J, Briand G, et al. How to measure exhaled breath MDA in normal subjects: assessment of two ionisation modes used by LCMS/MS. Eur Respir J. 2008;32(suppl 52):723.
2. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912-930.
3. Balbi B, Pignatti P, Corradi M, et al. Bronchoalveolar lavage, sputum, and exhaled clinically relevant inflammatory markers: values in healthy adults. Eur Respir J. 2007;30:769-781. (Pubitemid 351194840)
4. Pizzichini E, Pizzichini MMM, Leigh R, Djukanović R, Sterk PJ. Safety of sputum induction. Eur Respir J Suppl. 2002;37:9s-18s. (Pubitemid 35024262)
5. Snell N, Newbold P. The clinical utility of biomarkers in asthma and COPD. Curr Opin Pharmacol. 2008;8:222-235.
6. Chapman EA, Thomas PS, Yates DH. Breath analysis in asbestos-related disorders: a review of the literature and potential future applications. J Breath Res. 2010;4:034001.
7. Caglieri A, Goldoni M, Acampa O, et al. The effect of inhaled chromium on different exhaled breath condensate biomarkers among chrome-plating workers. Environ Health Perspect. 2006;114:542-546.
8. Goldoni M, Caglieri A, De Palma G, et al. Chromium in exhaled breath condensate (EBC), erythrocytes, plasma, and urine in the biomonitoring of chrome-plating workers exposed to soluble Cr (VI). J Environ Monit. 2010;12:442-447.
9. Goldoni M, Catalani S, De Palma G, et al. Exhaled breath condensate as a suitable matrix to assess lung dose and effects in workers exposed to cobalt and tungsten. Environ Health Perspect. 2004;112:1293-1298. (Pubitemid 39294967)
10. Hoffmeyer F, Weiss T, Lehnert M, et al. Increased metal concentrations in exhaled breath condensate of industrial welders. J Environ Monit. 2011;13:212-218.
11. Vignola AM, Rennar SI, Hargreave FE, et al. Standardised methodology of sputum induction and processing. Future directions. Eur Respir J Suppl. 2002;37:51s-55s.
12. Hillas G, Loukides S, Kostikas K, Bakakos P. Biomarkers obtained by noninvasive methods in patients with COPD: where do we stand, what do we expect? Curr Med Chem. 2009;16:2824-2838.
13. De Vuyst P, Karjalainen A, Dumortier P, et al. Guidelines for mineral fibre analyses in biological samples: report of the ERS Working Group. European Respiratory Society. Eur Respir J. 1998;11:1416-1426. (Pubitemid 28298611)
14. Pairon JC, Dumortier P. Role of biometric analysis in the retrospective assessment of exposure to asbestos. Rev Mal Respir. 1999;16(pt 2):1219-1235. (Pubitemid 30014271)
15. Teschler H, Thompson AB, Dollenkamp R, Konietzko N, Costabel U. Relevance of asbestos bodies in sputum. Eur Respir J. 1996;9:680-686. (Pubitemid 26167871)
16. Quirce S, Lemière C, de Blay F, et al. Noninvasive methods for assessment of airway inflammation in occupational settings. Allergy. 2010;65:445-458.
17. Dodig S, Richter D, Zrinski-Topić R. Inflammatory markers in childhood asthma. Clin Chem Lab Med. 2011;49:587-599.
18. Fernández-Nieto M, Sastre B, Sastre J, et al. Changes in sputum eicosanoids and inflammatory markers after inhalation challenges with occupational agents. Chest. 2009;136:1308-1315.
19. Corradi M, Pignatti P, Manini P, et al. Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation. Eur Respir J. 2004;24:1011-1017. (Pubitemid 39642294)
20. van der Vaart H, Postma DS, Timens W, et al. Repeated sputum inductions induce a transient neutrophilic and eosinophilic response. Chest. 2006;130:1157-1164. (Pubitemid 44583748)
21. Pala G, Pignatti P, Moscato G. The use of fractional exhaled nitric oxide in investigation of work-related cough in a hairdresser. Am J Ind Med. 2011;54:565-568.
22. Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602-615.
23. Lemière C, D'Alpaos V, Chaboillez S, et al. Investigation of occupational asthma: sputum cell counts or exhaled nitric oxide? Chest. 2010;137:617-622.
24. 2 in humans: effect of dynamically changing flow rate. J Appl Physiol. 1998;85:642-652. (Pubitemid 28365834)
25. Kerckx Y, Michils A, Van Muylem A. Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients. J Appl Physiol. 2008;104:918-924. (Pubitemid 351507926)
26. Smith AD, Cowan JO, Filsell S, et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med. 2004;169:473-478. (Pubitemid 38187119)
27. Barbinova L, Baur X. Increase in exhaled nitric oxide (eNO) after work-related isocyanate exposure. Int Arch Occup Environ Health. 2006;79:387-395.
28. Ferrazzoni S, Scarpa MC, Guarnieri G, et al. Exhaled nitric oxide and breath condensate pH in asthmatic reactions induced by isocyanates. Chest. 2009;136:155-162.
29. Baur X, Barbinova L. Latex allergen exposure increases exhaled nitric oxide in symptomatic healthcare workers. Eur Respir J. 2005;25:309-316. (Pubitemid 40246532)
30. Hewitt RS, Smith AD, Cowan JO, et al. Serial exhaled nitric oxide measurements in the assessment of laboratory animal allergy. J Asthma. 2008;45:101-107. (Pubitemid 351416960)
31. de Broucker V, Hulo S, Cherot-Kornobis N, et al. Interest of exhaled biomarkers in occupational asthma to latex: a case report. Arch Environ Occup Health. doi: 10.1080/19338244.2011.619213.
32. Swierczyńska-Machura D, Krakowiak A, Wiszniewska M, et al. Exhaled nitric oxide levels after specific inahalatory challenge test in subjects with diagnosed occupational asthma. Int J Occup Med Environ Health. 2008;21:219-225.
33. Demange V, Bohadana A, Massin N, Wild P. Exhaled nitric oxide and airway hyperresponsiveness in workers: a preliminary study in lifeguards. BMC Pulm Med. 2009;9:53.
34. Dressel H, Gross C, de la Motte D, et al. Educational intervention in farmers with occupational asthma: long-term effect on exhaled nitric oxide. J Investig Allergol Clin Immunol. 2009;19:49-53.
35. Horváth I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005;26:523-548. (Pubitemid 41264218)
36. Koutsokera A, Loukides S, Gourgoulianis KI, Kostikas K. Biomarkers in the exhaled breath condensate of healthy adults: mapping the path towards reference values. Curr Med Chem. 2008;15:620-630. (Pubitemid 351516819)
37. Antczak A, Nowak D, Shariati B, et al. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J. 1997;10:1235-1241. (Pubitemid 27278239)
38. Horváth I, Donnelly LE, Kiss A, et al. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med. 1998;158:1042-1046. (Pubitemid 28488999)
39. Psathakis K, Mermigkis D, Papatheodorou G, et al. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. Eur J Clin Invest. 2006;36:362-367.
40. 2 level in exhaled breath condensate in primary breast cancer patients. J Cancer Res Clin Oncol. 2010;136:923-930.
41. Chow S, Campbell C, Sandrini A, et al. Exhaled breath condensate biomarkers in asbestos-related lung disorders. Respir Med. 2009;103:1091-1097.
42. Ganas K, Loukides S, Papatheodorou G, Panagou P, Kalogeropoulos N. Total nitrite/nitrate in expired breath condensate of patients with asthma. Respir Med. 2001;95:649-654. (Pubitemid 32785520)
43. Corradi M, Gergelova P, Di Pilato E, et al. Effect of exposure to detergents and other chemicals on biomarkers of pulmonary response in exhaled breath from hospital cleaners: a pilot study. Int Arch Occup Environ Health. doi: 10.1007/s00420-011-0686-8.
44. Gube M, Ebel J, Brand P, et al. Biological effect markers in exhaled breath condensate and biomonitoring in welders: impact of smoking and protection equipment. Int Arch Occup Environ Health. 2010;83:803-811.
45. Corradi M, Alinovi R, Goldoni M, et al. Biomarkers of oxidative stress after controlled human exposure to ozone. Toxicol Lett. 2002;134:219-225. (Pubitemid 35007304)
46. Teng Y, Sun P, Zhang J, et al. Hydrogen peroxide in exhaled breath condensate in patients with asthma: a promising biomarker? Chest. 2011;140:108-116.
47. Morrow JD, Hill KE, Burk RF, et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 1990;87:9383-9387. (Pubitemid 120030630)
48. Delanty N, Reilly M, Pratico D, et al. 8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. Br J Clin Pharmacol. 1996;42:15-19. (Pubitemid 26230049)
49. Wood LG, Gibson PG, Garg ML. Biomarkers of lipid peroxidation, airway inflammation, and asthma. Eur Respir J. 2003;21:177-186. (Pubitemid 36150317)
50. Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. FASEBJ. 2004;18:1791-1800. (Pubitemid 39602265)
51. Janicka M, Kot-Wasik A, Kot J, Namiésnik J. Isoprostanes- biomarkers of lipid peroxidation: their utility in evaluating oxidative stress and analysis. Int J Mol Sci. 2010;11:4631-4659.
52. Kiełbasa B, Moeller A, Sanak M, et al. Eicosanoids in exhaled breath condensates in the assessment of childhood asthma. Pediatr Allergy Immunol. 2008;19:660-669.
53. Carraro S, Cogo PE, Isak I, et al. EIA and GC/MS analysis of 8-isoprostane in EBC of children with problematic asthma. Eur Respir J. 2010;35:1364-1369.
54. Sanak M, Gielicz A, Nagraba K, et al. Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:1796-1800.
55. Zhang B, Saku K. Control of matrix effects in the analysis of urinary F2isoprostanes using novel multidimensional solid-phase extraction and LCMS/MS. J Lipid Res. 2007;48:733-744. (Pubitemid 46397477)
56. Klusackova P, Lebedova J, Kacer P, et al. Leukotrienes and 8-isoprostane in exhaled breath condensate in bronchoprovocation tests with occupational allergens. Prostaglandins Leukot Essent Fatty Acids. 2008;78:281-292. (Pubitemid 351794239)
57. Pelclová D, Fenclová Z, Kacer P, et al. 8-isoprostane and leukotrienes in exhaled breath condensate in Czech subjects with silicosis. Ind Health. 2007;45:766-774. (Pubitemid 351185055)
58. Syslová K, Kacer P, Kuzma M, et al. Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silicainduced lung diseases. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:2477-2486.
59. Syslová K, Kačer P, Kuzma M, et al. LC-ESI-MS/MS method for oxidative stress multimarker screening in the exhaled breath condensate of asbestosis/silicosis patients. J Breath Res. 2010;4:017104.
60. Syslová K, Kacer P, Kuzma M, et al. Determination of 8-iso-prostaglandin F2[alpha] in exhaled breath condensate using combination of immunoseparation and LC-ESI-MS/MS. J Chromatograp B. 2008;867:8-14.
61. Kostikas K, Papatheodorou G, Ganas K, et al. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med. 2002;165:1364-1370. (Pubitemid 34522938)
62. Zanconato S, Carraro S, Corradi M, et al. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol. 2004;113:257-263. (Pubitemid 38210547)
63. Simpson JL, Wood LG, Gibson PG. Inflammatory mediatorsinexhaledbreath, induced sputum, and saliva. Clin Exp Allergy. 2005;35:1180-1185. (Pubitemid 43922145)
64. Rosias PP, Robroeks CM, Niemarkt HJ, et al. Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate. Eur Respir J. 2006;28:1036-1041. (Pubitemid 46331976)
65. Tufvesson E, Bjermer L. Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate. Respir Med. 2006;100:34-38. (Pubitemid 43033377)
66. Robroeks CMHHT, van de Kant KDG, Jöbsis Q, et al. Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma. Clin Exp Allergy. 2007;37:1303-1311. (Pubitemid 47372295)
67. Samitas K, Chorianopoulos D, Vittorakis S, et al. Exhaled cysteinylleukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity. Respir Med. 2009;103:750-756.
68. Caballero Balanzá S, Martorell Aragonés A, Cerdá Mir JC, et al. Leukotriene B4 and 8-isoprostane in exhaled breath condensate of children with episodic and persistent asthma. J Investig Allergol Clin Immunol. 2010;20:237-243.
69. Brussino L, Badiu I, Sciascia S, et al. Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis. Clin Exp Allergy. 2010;40:1642-1647.
70. Papaioannou AI, Mazioti A, Kiropoulos T, et al. Systemic and airway inflammation and the presence of emphysema in patients with COPD. Respir Med. 2010;104:275-282.
71. Pelclová D, Fenclová Z, Kacer P, et al. Increased 8-isoprostane, a marker of oxidative stress in exhaled breath condensate in subjects with asbestos exposure. Ind Health. 2008;46:484-489.
72. Lehtimäki L, Oksa P, Järvenpää R, et al. Pulmonary inflammation in asbestosexposed subjects with borderline parenchymal changes on HRCT. Respir Med. 2010;104:1042-1049.
73. Do R, Bartlett KH, Dimich-Ward H, Chu W, Kennedy SM. Biomarkers of airway acidity and oxidative stress in exhaled breath condensate from grain workers. Am. J. Respir. Crit. Care Med. 2008;178:1048-1054.
74. Hoffmeyer F, Harth V, Bunger J, Bruning T, Raulf-Heimsoth M. Leukotriene B4, 8-iso-prostaglandin F2 alpha, and pH in exhaled breath condensate from asymptomatic smokers. J Physiol Pharmacol. 2009;60(suppl 5):57-60.
75. Marnett LJ. Oxy radicals, lipid peroxidation, and DNA damage. Toxicology. 2002;181-182:219-222.
76. Lärstad M, Ljungkvist G, Olin A-C, Torén K. Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;766:107-114. (Pubitemid 34142381)
77. Romieu I, Barraza-Villarreal A, Escamilla-Nuñez C, et al. Exhaled breath malondialdehyde as a marker of effect of exposure to air pollution in children with asthma. J Allergy Clin Immunol. 2008;121:903-909.
78. Vagaggini B, Bartoli MLE, Cianchetti S, et al. Increase in markers of airway inflammation after ozone exposure can be observed also in stable treated asthmatics with minimal functional response to ozone. Respir Res. 2010;11:5.
79. Corradi M, Folesani G, Andreoli R, et al. Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am JRespir Crit Care Med. 2003;167:395-399. (Pubitemid 36216422)
80. Corradi M, Rubinstein I, Andreoli R, et al. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167:1380-1386. (Pubitemid 36609723)
81. Andreoli R, Manini P, Corradi M, Mutti A, Niessen WMA. Determination of patterns of biologically relevant aldehydes in exhaled breath condensate of healthy subjects by liquid chromatography/atmospheric chemical ionization tandem mass spectrometry. Rapid Commun Mass Spectrom. 2003;17:637-645. (Pubitemid 36373162)
82. Dut R, Dizdar EA, Birben E, et al. Oxidative stress and its determinants in the airways of children with asthma. Allergy. 2008;63:1605-1609.
83. Kostikas K, Koutsokera A, Papiris S, Gourgoulianis KI, Loukides S. Exhaled breath condensate in patients with asthma: implications for application in clinical practice. Clin Exp Allergy. 2008;38:557-565. (Pubitemid 351406070)
84. Robbins RA, Hadeli K, Nelson D, Sato E, Hoyt JC. Nitric oxide, peroxynitrite, and lower respiratory tract inflammation. Immunopharmacology. 2000;48:217-221.
85. Mehta V, Stokes JR, Berro A, Romero FA, Casale TB. Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma. Ann Allergy Asthma Immunol. 2009;103:31-37.
86. Corradi M, Gergelova P, Mutti A. Use of exhaled breath condensate to investigate occupational lung diseases. Curr Opin Allergy Clin Immunol. 2010;10:93-98.
87. Murgia N, Muzi G, Dell' Omo M, et al. Induced sputum, exhaled breath condensate, and nasal lavage fluid in electroplating workers exposed to chromium. Int J Immunopathol Pharmacol. 2006;19(suppl):67-71.
88. Brand P, Gube M, Gerards K, et al. Internal exposure, effect monitoring, and lung function in welders after acute short-term exposure to welding fumes from different welding processes. J Occup Environ Med. 2010;52:887-892.
89. Chérot-Kornobis N, Hulo S, Edmé J-L, et al. Analysis of nitrogen oxides (NOx) in the exhaled breath condensate (EBC) of subjects with asthma as a complement to exhaled nitric oxide (FeNO) measurements: a cross-sectional study. BMC Res Notes. 2011;4:202.
90. Falgayrac G, Chérot-Kornobis N, Broucker V de, et al. Noninvasive molecular identification of particulate matter in lungs by Raman microspectrometry. J Raman Spectroscopy. 2011;42:1484-1487.
91. Edmé JL, Tellart AS, Launay D, et al. Cytokine concentrations in exhaled breath condensates in systemic sclerosis. Inflamm Res. 2008;57:151-156.
92. van de Kant KDG, Klaassen EMM, Jöbsis Q, et al. Wheezing in preschool children is associated with increased levels of cytokines/chemokines in exhaled breath condensate. J Allergy Clin Immunol. 2010;126:669-671.
93. Robroeks CMHHT, Rijkers GT, Jöbsis Q, et al. Increased cytokines, chemokines, and soluble adhesion molecules in exhaled breath condensate of asthmatic children. Clin Exp Allergy. 2010;40:77-84.
94. Rosias PPR, Dompeling E, Dentener MA, et al. Childhood asthma: exhaled markers of airway inflammation, asthma control score, and lung function tests. Pediatr Pulmonol. 2004;38:107-114. (Pubitemid 38989729)
95. Ko FW, Leung T-F, Wong GW, et al. Measurement of tumor necrosis factoralpha, leukotriene B4, and interleukin-8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2009;4:79-86.